IP Library Granted Patent US 8,190,371
Granted Patent B2
US 8,190,371 · App. 12/206,436 · Granted May 29, 2012

Methods and applications for target quantification

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,190,371
App. No.
12/206,436
Granted
May 29, 2012
Kind
B2
Abstract

The present invention provides methods and software applications for quantifying a target in an experimental sample by collecting and processing initial signal data from the experimental sample and at least two standard control samples containing known target copy numbers. In this regards, the present invention allows the quantification of target copy number in the experimental sample.

Claims (30)

1. A method of quantifying a target in an experimental sample comprising:

a) measuring a nucleic acid detection assay signal at a plurality of time intervals from an experimental sample and at least two standard control samples containing known target copy numbers that are different, thereby generating signal data;

b) providing said signal data to a computer system, wherein said computer system has stored therein a target quantifying software application;

c) processing said signal data with said target quantifying software application such that said target quantifying software:

i) generates a threshold signal line having i) an initial signal value at time zero, and ii) a threshold slope; wherein said threshold signal line is above background level and intersects said experimental curve and two or more of said at least two standard control curves;

ii) processes said signal data and said threshold signal line to generate an experimental intersecting time value and at least two standard control intersecting time values;

iii) processes said at least two standard control intersecting time values and said known target copy numbers to generate log plot data comprising coordinates for a log/log plot, or a linear/log plot, of said intersecting time values versus said known target copy numbers;

iv) processes said log plot data to generate a slope equation describing a resulting slope fit to said log plot data; and

v) processes said experimental intersecting time value with said slope equation to generate a quantified target copy number for said experimental sample; and

d) transmitting said quantified target copy number to a user interface display.

2. The method of claim 1 , wherein said threshold slope of is zero, or wherein said threshold slope is negative.

3. The method of claim 1 , wherein said nucleic acid detection assay comprises an invasive cleavage assay.

4. The method of claim 1 , wherein said nucleic acid detection assay is performed under isothermal conditions.

5. The method of claim 1 , wherein said target comprises a nucleic acid sequence.

6. The method of claim 5 , wherein said nucleic acid sequence comprises a micro-RNA or siRNA sequence.

7. A system for quantifying a target in an experimental sample comprising:

a) a device configured to detect assay signal level at a plurality of time intervals from an experimental sample and at least two standard control samples containing known target copy numbers that are different, to generate initial signal data;

b) a target quantifying software application configured to:

i) process said initial signal data to generate signal data that is capable of being plotted as an experimental curve and at least two standard control curves;

ii) generate a threshold signal line having i) an initial signal value at time zero, and ii) a threshold slope; wherein said threshold signal line is above background, and intersects said experimental curve and two or more of said at least two standard control curves;

iii) process said signal data and said threshold signal line to generate an experimental intersecting time value and at least two standard control intersecting time values;

iv) process said at least two standard control intersecting time values and said known target copy numbers to generate log plot data comprising coordinates for a log/log plot, or linear/log plot, of said intersecting time values versus said known target copy numbers;

v) process said log plot data to generate a slope equation describing a resulting slope fit to said log plot data; and

vi) process said experimental intersecting time value with said slope equation to generate a quantified target copy number for said experimental sample; and

c) a computer system having stored therein said target quantifying software application, wherein said computer system comprises computer memory and a computer processor.

8. The system of claim 7 , wherein said target comprises a nucleic acid sequence.

9. The system of claim 8 , wherein said nucleic acid sequence comprises an RNA or DNA sequence.

10. The system of claim 7 , wherein said assay signal level is generated by a nucleic acid detection assay.

11. The system of claim 10 , wherein said nucleic acid detection assay comprises an invasive cleavage assay.

12. The system of claim 10 , wherein said nucleic acid detection assay is configured to run under isothermal conditions.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
MERGER Recorded Oct 23, 2015
From: THIRD WAVE AGBIO, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: GEN-PROBE INCORPORATED
Reel/Frame 036934/0796 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS Recorded Aug 26, 2010
From: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
To: HOLOGIC, INC.; R2 TECHNOLOGY, INC.; SUROS SURGICAL SYSTEMS, INC.; BIOLUCENT, LLC; DIRECT RADIOGRAPHY CORP.; CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS LIMITED PARTNERSHIP; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS III, INC.; CYTYC PRENATAL PRODUCTS CORP.; THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 024892/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2008
From: ALLAWI, HATIM T.; PIPER, REX
To: THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 021872/0199 →
SECOND SUPPLEMENT TO PATENT SECURITY AGREEMENT Recorded Nov 10, 2008
From: THIRD WAVE TECHNOLOGIES, INC.
To: GOLDMAN SACHS CREDIT PARTNERS LP, AS COLLATERAL AGENT
Reel/Frame 021811/0134 →